Fact CheckerSign in

NCT07297368Active, not recruiting

Enhanced Tai Chi for Parkinson's Disease (Enhanced Tai Chi PD)

Enhanced Tai Chi: A Randomised, Controlled, Single-Site Study of the Effects of Enhanced Tai Chi Training on Motor and Non-Motor Symptoms of Parkinson's Disease: A Pilot Study

Source: ClinicalTrials.gov · Last updated 31 Dec 2025

Brief summary (registry, in English)

This pilot study evaluates whether a structured, Parkinson's disease-specific Tai Chi programme ("Enhanced Tai Chi") can improve motor and non-motor symptoms in people with Parkinson's disease (PD). PD is a progressive neurological condition associated with motor impairments such as bradykinesia, rigidity, gait disturbance and postural instability, as well as non-motor symptoms including fatigue, pain, mood disturbance, sleep problems and cognitive changes. Although pharmacological treatments improve many motor symptoms, balance and postural control often respond poorly, contributing to falls and reduced independence. Enhanced Tai Chi is a tailored programme developed specifically for people with PD, incorporating elements of Tai Chi and Qi Gong focused on balance control, coordination, postural alignment, body awareness and confidence in movement. This single-site, randomised, controlled pilot trial will enrol 30 adults with idiopathic PD (Hoehn \& Yahr stages I-III), randomised in a 2:1 ratio to Enhanced Tai Chi plus usual clinical care or usual clinical care alone. Participants in the intervention group will complete 36 supervised one-hour sessions over 12 weeks (three sessions per week: one in-person and two delivered remotely), with optional independent practice encouraged. Adherence will be monitored through attendance records. Outcomes will be assessed at baseline, post-intervention and 3-month follow-up. Findings will inform feasibility, acceptability and preliminary efficacy estimates to support the design of a future definitive randomised controlled trial.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (actual)
First submitted
9 Dec 2025
Start date
1 May 2024
Primary completion date
1 Apr 2026
Lead sponsor
King's College Hospital NHS Trust
NCT number
NCT07297368

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 1 May 2024 to the primary completion date, 1 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Advanced therapies (DBS, apomorphine infusion, jejunal levodopa)

Other illness

  • Dementia (MoCA ≤ 21)
  • Other neurological or medical conditions limiting participation

Other

  • Atypical or secondary parkinsonism
  • Inability to commit to scheduled sessions

Who the study is looking for

  • Idiopathic Parkinson's disease (Hoehn \& Yahr stage I-III)
  • Able to stand and participate in movement sessions
  • Stable medication dose for ≥ 4 weeks before study entry

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
King's College Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.